[go: up one dir, main page]

ES8801269A1 - Un procedimiento para preparar benzo(c)-1,5-naftiridinas - Google Patents

Un procedimiento para preparar benzo(c)-1,5-naftiridinas

Info

Publication number
ES8801269A1
ES8801269A1 ES557207A ES557207A ES8801269A1 ES 8801269 A1 ES8801269 A1 ES 8801269A1 ES 557207 A ES557207 A ES 557207A ES 557207 A ES557207 A ES 557207A ES 8801269 A1 ES8801269 A1 ES 8801269A1
Authority
ES
Spain
Prior art keywords
formula
naphthyridines
medicaments
benzo
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557207A
Other languages
English (en)
Other versions
ES557207A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES557207A0 publication Critical patent/ES557207A0/es
Publication of ES8801269A1 publication Critical patent/ES8801269A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE BENZOC-1,5-NAFTIRIDINAS Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I). COMPRENDE LA REACCION DE REDUCCION DE UN COMPUESTO DE FORMULA (I), EN LA QUE R1 REPRESENTA OXIGENO Y R ES ALQUILO, ARILALQUILO O DIARILALQUILO INFERIORES, PARA FORMAR UN COMPUESTO DE FORMULA (I) EN LA QUE R Y R1 SON HIDROGENO Y X PUEDE SER UNO DE VARIOS TIPOS DE RADICALES. LA REDUCCION SE EFECT''A CON DIBORANO, EN TETRAHIDROFURANO ANHIDRO, A LA TEMPERATURA AMBIENTE. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA REFORZAR LA MEMORIA.
ES557207A 1985-03-13 1986-11-17 Un procedimiento para preparar benzo(c)-1,5-naftiridinas Expired ES8801269A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/711,327 US4652567A (en) 1985-03-13 1985-03-13 Benzo(c)-1,5-naphthyridines useful for treating a patient having drug induced memory impairment in need of memory enhancement

Publications (2)

Publication Number Publication Date
ES557207A0 ES557207A0 (es) 1988-01-01
ES8801269A1 true ES8801269A1 (es) 1988-01-01

Family

ID=24857642

Family Applications (4)

Application Number Title Priority Date Filing Date
ES552874A Expired ES8707528A1 (es) 1985-03-13 1986-03-11 Un procedimiento para preparar benzo (c)-1,5-naftiridinas
ES557208A Expired ES8800941A1 (es) 1985-03-13 1986-11-17 Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina
ES557207A Expired ES8801269A1 (es) 1985-03-13 1986-11-17 Un procedimiento para preparar benzo(c)-1,5-naftiridinas
ES557768A Expired ES8801270A1 (es) 1985-03-13 1987-10-15 Un procedimiento para preparar benzo (c)-1,5-naftiridinas

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES552874A Expired ES8707528A1 (es) 1985-03-13 1986-03-11 Un procedimiento para preparar benzo (c)-1,5-naftiridinas
ES557208A Expired ES8800941A1 (es) 1985-03-13 1986-11-17 Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557768A Expired ES8801270A1 (es) 1985-03-13 1987-10-15 Un procedimiento para preparar benzo (c)-1,5-naftiridinas

Country Status (19)

Country Link
US (1) US4652567A (es)
EP (1) EP0197318B1 (es)
JP (1) JPS61212585A (es)
KR (1) KR860007255A (es)
AT (1) ATE52510T1 (es)
AU (1) AU590748B2 (es)
CA (1) CA1248108A (es)
DE (1) DE3671017D1 (es)
DK (1) DK114386A (es)
ES (4) ES8707528A1 (es)
FI (1) FI861001A7 (es)
GR (1) GR860681B (es)
HU (2) HU201756B (es)
IL (1) IL78117A0 (es)
NO (1) NO163489B (es)
NZ (1) NZ215439A (es)
PH (1) PH22279A (es)
PT (1) PT82187B (es)
ZA (1) ZA861837B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766217A (en) * 1984-01-13 1988-08-23 Boehringer Ingelheim Kg Preparation of 5,6-dihydro-pyrrolo[2,1-a]isoquinolines
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
US5994367A (en) * 1997-03-07 1999-11-30 The University Of North Carolina At Chapel Hill Method for treating tumors using 2-aryl-naphthyridin-4-ones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2273533A1 (fr) * 1974-06-04 1976-01-02 Ferlux Sa Nouveaux derives n-substitues d'acides pyrrolidones-2 carboxyliques-5
US4297358A (en) * 1979-01-16 1981-10-27 Ciba-Geigy Corporation Novel 4,7-phenanthroline derivatives and pharmaceutical compositions containing them and their use
BE880455A (fr) * 1979-01-22 1980-06-06 Sandoz Sa Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine

Also Published As

Publication number Publication date
HU201756B (en) 1990-12-28
HUT40658A (en) 1987-01-28
CA1248108A (en) 1989-01-03
ES557208A0 (es) 1987-12-01
IL78117A0 (en) 1986-07-31
US4652567A (en) 1987-03-24
NZ215439A (en) 1990-03-27
AU5465886A (en) 1986-09-18
DK114386A (da) 1986-09-14
DE3671017D1 (de) 1990-06-13
HU197007B (en) 1989-02-28
ATE52510T1 (de) 1990-05-15
ES8800941A1 (es) 1987-12-01
NO163489B (no) 1990-02-26
ES557207A0 (es) 1988-01-01
ES8707528A1 (es) 1987-08-01
FI861001A7 (fi) 1986-09-14
DK114386D0 (da) 1986-03-12
KR860007255A (ko) 1986-10-10
EP0197318A1 (en) 1986-10-15
AU590748B2 (en) 1989-11-16
PT82187B (en) 1988-01-07
ZA861837B (en) 1987-06-24
ES8801270A1 (es) 1988-01-01
NO860933L (no) 1986-09-15
EP0197318B1 (en) 1990-05-09
JPS61212585A (ja) 1986-09-20
GR860681B (en) 1986-07-14
ES557768A0 (es) 1988-01-01
FI861001A0 (fi) 1986-03-11
PT82187A (en) 1986-04-01
PH22279A (en) 1988-07-14
ES552874A0 (es) 1987-08-01

Similar Documents

Publication Publication Date Title
NO159795C (no) Fremgangsmaate for fremstilling av 2-penemforbindelser.
ES8800172A1 (es) Procedimiento para la preparacion de 3-ariluracilos
ES8704965A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
DK164903C (da) Substituerede imidazolderivater og fremgangsmaader til fremstilling deraf
DE69001187D1 (de) 6-epifumagillole, ihre herstellung und ihre verwendung.
ATE65500T1 (de) Arylthioalkylphenylcarbonsaeuren, diese enthaltende zusammensetzungen und deren verwendung.
DE3167908D1 (de) Use of 1,3-dioxolen-2-one derivatives
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES2007543A6 (es) Procedimiento de preparacion de 1,4-dihidropiridinas.
ES8301978A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles.
ES8705408A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina.
ES2040213T3 (es) Nuevos derivados de 3-oxadiazol- y 3-(ester de acido carboxilico)-beta-carbolina, su preparacion y su utilizacion como medicamentos.
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
ATE34394T1 (de) Therapeutisch aktive di-, tri-, tetra- und penta- aza-indene.
ES8800671A1 (es) Procedimiento para preparar 5-pirimidin-carboxamidas sustituidas con actividad anti-leucemia
ES539123A0 (es) Un compuesto de 3-indolcarboxamida
ES8801269A1 (es) Un procedimiento para preparar benzo(c)-1,5-naftiridinas
ES8302699A1 (es) Procedimiento para la preparacion de nuevos benzoxazoles y benzotiazoles.
ES8703428A1 (es) Procedimiento para la obtencion de compuestos de amida
ES2052526T3 (es) Derivados de pirimidina, su preparacion y medicamentos que contienen estos derivados.
ES8702390A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina
DE3280255D1 (de) Herstellung von substituierten gamma-butyrolactonen, verwendbar als zwischenprodukte zur herstellung von fungiziden imidazolen und triazolen.
ES8708139A1 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas.
ES8205215A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido acetico.
ES8705440A1 (es) Un procedimiento para la produccion de 2h-imidazo-(1',2':1,2)-pirrolo-(3,4-b)-piridinas

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960401